At a glance
- Originator Banyu
- Class Cyclohexanes; Xanthenes
- Mechanism of Action Neuropeptide Y5 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Obesity
Most Recent Events
- 17 Dec 2003 No development reported - Preclinical for Obesity in Japan (PO)
- 17 Jul 2001 Preclinical development for Obesity in Japan (PO)